By Sahil Pandey March 10 (Reuters) - Medical device maker Medtronic said on Tuesday it would buy U.S.-based Scientia Vascular ...

Medtronic announced today that it has entered into a definitive agreement to acquire Scientia Vascular for $550 million.

GlobalData analyst Dr Andrew S Thompson’s states Medtronic could significantly grow Scientia’s micro guidewire franchise if they can replicate its US success on the international stage.

Medtronic today announced its entry into a definitive agreement to acquire Scientia Vascular, a company with critical, innovative technology across the neurovascular portfolio. The acquisition is ...

Medtronic acquire neurovascular device company Scientia Vascular for $550 million, expanding its portfolio with guidewires and catheters.

Sleep Number's new CEO is planning to make the bed manufacturer profitable with a smaller product lineup. Also, Medtronic has ...

Medtronic (NYSE:MDT) continues to lead in medical technology, making significant contributions to the S&P 500 Chart ...

Expanding the long-running partnership will bring Medtronic technologies, such as the Nellcor pulse oximetry product, to more healthcare settings.

In early March 2026, Medtronic reported stronger-than-expected Q3 2026 results with 6% year-over-year organic revenue growth and affirmed a US$0.71 quarterly dividend per share, extending its 48-year ...

Since its U.S. launch in 2002, a unique product developed by Medtronic to promote bone growth has been used to mend the ailing backs of thousands of patients and has reaped millions for the Fridley ...

Two patients who were injured by Medtronic's controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor ...

Medtronic (NYSE:MDT) has been found liable for violating U.S. antitrust laws in the advanced bipolar devices market. A ...